General Information


DRAVP ID  DRAVPe00761

Peptide Name   IN(1-10)[C3S]

Sequence  WQSLTLTHRG

Sequence Length  10

UniProt ID  No entry found

Source  Synthetic construct



Activity Information


Target Organism  HIV

Assay  MAGI assay

Activity 

  • [Ref.19850483]HIV-1:inhibition of integrase catalytic activity(62% inhibition at 62.5μM);inhibition of virus replication in TZM-bl cells(60% inhibition at 62.5μM);inhibition of intergration(51% inhibition at 62.5μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  Integrase

Mechanism  The peptide can inhibit integrase and thus inhibit virus replication.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00761

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C53H83N17O15

Absent amino acids  ACDEFIKMNPVY

Common amino acids  LT

Mass  1198.35

Pl  9.76

Basic residues  2

Acidic residues  0

Hydrophobic residues  3

Net charge  2

Boman Index  -2055

Hydrophobicity  -71

Aliphatic Index  78

Half Life 

  •     Mammalian:2.8 hour
  •     Yeast:3 min
  •     E.coli:2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  611.11

Polar residues  4



Literature Information


Literature 1

Title   Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.

Pubmed ID   19850483

Reference   Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.

Author   Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. 

DOI   10.1016/j.bmc.2009.09.053